PHAT Q2 2019 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PHATPhathom Pharmaceuticals, Inc.

$831M

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$83M

Net Income

-$88M

EPS (Diluted)

$-10.23

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$29,000

Balance Sheet

Total Assets

$85M

Total Liabilities

$169M

Stockholders' Equity

-$84M

Cash & Equivalents

$83M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$83M	-$253,000	-32711.9%
Net Income	-$88M	-$257,000	-34048.6%